AOD-9604 – 5mg

AOD 9604 Buy: Research-Grade Lipolytic GH Fragment Peptide

Are you exploring AOD 9604 buy options for lipolysis and metabolic pathway research? Sino Research Peptide Manufacturer supplies AOD 9604, a synthetic analog of growth hormone designed to study fat metabolism and lipolytic pathway activity in laboratory settings.

What Is AOD 9604 Peptide?

AOD 9604 is a modified fragment of growth hormone, reproducing the last 16 amino acids (176–191) of the hGH molecule — also known as GH Fragment 176-191. The peptide includes a tyrosine residue replacing the first N-terminal amino acid, a modification researchers believe helps increase peptide stability.(1)

Researchers consider AOD 9604 the lipolytic fragment of GH, since different regions of the GH molecule appear to carry different functions. Studies suggest the N-terminal region of the 191-amino-acid GH structure exhibits insulin-potentiating action, while amino acids 108–129 evoke high mitogenic responses.(2)

What Does AOD 9604 Do in Research?

Scientists developed AOD 9604 in the 1990s while working to create proteins that might exhibit anti-obesity properties similar to growth hormone. Since then, researchers have conducted rigorous studies to determine the peptide’s potential role in lipolysis — the process through which stored fats break down into glycerol and free fatty acids that other cells can use for energy.(1)

Enzymes such as lipase appear central to this breakdown process. Research suggests AOD 9604 may influence fat cells and lipolytic receptors, particularly given its observed association with weight and fat changes in murine models. Findings indicate the fragment may amplify lipolytic sensitivity following exposure.

Studies also hypothesize a potential interaction between AOD 9604 buy and the beta-adrenergic pathway, specifically beta(3)-adrenergic receptors (beta(3)-AR) — key lipolytic receptors in fat cells. Researchers observed increased beta(3)-AR RNA expression in the presence of AOD 9604, suggesting the peptide might enhance lipolytic receptor sensitivity, even though it may not act directly through beta(3)-AR to produce its lipolytic effects.

Researchers suggest the modified hGH portion in AOD 9604 may induce fat-burning processes without stimulating IGF-1 production, unlike natural growth hormone.

Chemical Makeup of AOD 9604

AOD 9604 Peptide Benefits in Research: What Studies Show

When researchers explore AOD 9604 peptide benefits, they’re typically referring to the compound’s documented research applications across lipolysis, metabolic health, cell regeneration, and cancer cell studies.

AOD 9604 and Lipolytic Activity Research

Early studies introduced AOD 9604 buy to obese mice periodically over 14 days. Results showed reduced weight and excess fat, correlating directly with increased beta(3)-AR levels in fat cells. AOD 9604 appeared to act similarly to hGH, with both capable of increasing repressed lipolytic receptor levels in obese mice compared to lean mice.

To determine whether AOD 9604’s lipolytic action depended solely on increased receptor levels, researchers tested the peptide on mice with knocked-out lipolytic receptors. This analysis suggested AOD 9604 may drive lipolytic action through increased energy expenditure and fat oxidation, rather than through beta(3)-AR expression alone.(1)

A 2000 study tested obese Zucker rats with daily AOD 9604 exposure over 19 consecutive days. Results showed weight reductions exceeding 50% compared to placebo-treated rats. Further analysis showed increased adipose tissue lipolytic activity with no marked disruption to insulin sensitivity.(3)

AOD 9604 Buy and Obesity Research

A 2004 clinical trial observed AOD 9604’s effects in 300 obese subjects over 12 weeks. Weight loss rates remained consistent throughout the study period, and researchers noted minor improvements in cholesterol profiles and glucose tolerance levels.(4)

AOD 9604 and Cell Regeneration Research

A 2015 study divided 32 white rabbits into four groups of eight, testing placebo, AOD 9604, hyaluronic acid, and a combination of AOD 9604 with hyaluronic acid over 4 to 7 weeks. Morphological and histopathological assessment showed rabbits given the AOD 9604 and hyaluronic acid combination exhibited the least cartilage degeneration, suggesting AOD 9604 may support cartilage regeneration and repair.(5)

This may relate to AOD 9604’s potential role in cellular differentiation and protein synthesis important for tissue repair. In vitro research suggests AOD 9604 may enhance differentiation of adipose mesenchymal stem cells into bone cells.(5) Research on isolated bovine chondrocytes also showed increased proteoglycan and collagen production, key components of the cartilage extracellular matrix.

The same research suggests AOD 9604 might promote differentiation of myoblasts (precursor muscle cells) into C2C12 cells, a murine muscle cell line — pointing toward a potential role in bone, cartilage, and muscle tissue repair processes.

AOD 9604 and Cancer Cell Research

Research suggests AOD 9604 may bind tumor-related proteins to enhance tumor drug accumulation and local cytotoxicity.(6) One study explored AOD 9604’s potential to enhance the anticancer efficacy of doxorubicin, a widely used chemotherapeutic agent, using chitosan nanoparticles as a delivery carrier for both compounds.(6)

Researchers hypothesized AOD 9604 enhanced doxorubicin binding to multiple breast cancer cell protein targets, showing greater anti-proliferative activity against the MCF-7 breast cancer cell line compared to chitosan-delivered doxorubicin alone. This suggests AOD 9604 may augment doxorubicin’s anti-cancer potency while potentially minimizing unintended effects on non-target tissue.

Across multiple studies, researchers suggest AOD 9604 may significantly induce lipolysis and potentially prevent lipogenesis by mimicking natural hGH activity.

Where to Buy AOD 9604 Peptide

AOD 9604 Buy Peptide, Where to Buy: What to Check

When you compare where to buy AOD 9604 peptide, purity documentation and batch consistency should top your checklist. Sino Research Peptide Manufacturer verifies identity and purity on every batch.

Best Place to Buy AOD 9604

Sino Research Peptide Manufacturer ships high-purity AOD 9604 backed by rigorous internal quality checks, making it a reliable choice whether you’re studying lipolytic pathways, cartilage regeneration, or cancer cell research.

AOD 9604 Buy Online at Sino Research Peptide Manufacturer

Ready to buy AOD 9604 online? Sino Research Peptide Manufacturer makes ordering straightforward, with documented quality on every batch shipped to your lab.

Order / AOD 9604  BuyPeptide Today

Ready to add AOD 9604 to your research pipeline? Sino Research Peptide Manufacturer supplies consistent, research-grade material for every study.

AOD 9604 is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering.

References:

1. Mark Heffernan, Roger J. Summers, Anne Thorburn, Esra Ogru, Robert Gianello, Woei-Jia Jiang, Frank M. Ng, The Effects of Human GH and Its Lipolytic Fragment (AOD 9604) on Lipid Metabolism Following Chronic Treatment in Obese Mice and β 3-AR Knock-Out Mice, Endocrinology, Volume 142, Issue 12, 1 December 2001, Pages 5182–5189. https://pubmed.ncbi.nlm.nih.gov/11713213/
2. Moré, M. I., & Kenley, D. (2014). Safety and metabolism of AOD9604, a novel nutraceutical ingredient for improved metabolic health. Journal of Endocrinology and Metabolism, 4(3), 64-77.
3. Frank M. Ng, J Sun et.al, Metabolic Studies of a Synthetic Lipolytic Domain (AOD 9604) of Human Growth Hormone, Hormone Research, February 2000.
4. News, Medical and Life Sciences, Obesity drug codenamed AOD 9604 highly successful in trials, 16 December 2004.
5. Dong Rak Kwon and GI Young Park, Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model, Annals of Clinical and Laboratory Science, Volume 45, July-August 2015.
6. Habibullah, M. M., Mohan, S., Syed, N. K., Makeen, H. A., Jamal, Q. M. S., Alothaid, H., Bantun, F., Alhazmi, A., Hakamy, A., Kaabi, Y. A., Samlan, G., Lohani, M., Thangavel, N., & Al-Kasim, M. A. (2022). Human Growth Hormone Fragment 176-191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer Cells. Drug design, development and therapy, 16, 1963–1974. https://doi.org/10.2147/DDDT.S367586